1-12 of 12
Lixin Rui
Close
Sort by
Journal Articles

EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphoma

Yunxia Liu, Shuichi Kimpara, Nguyet M. Hoang, Anusara Daenthanasanmak, Yangguang Li, Li Lu, Vu N. Ngo, Paul D. Bates, Longzhen Song, Xiaoyue Gao, Samantha Bebel, Madelyn Chen, Ruoyu Chen, Xiyu Zhang, Paul E. Selberg, Vaishalee P. Kenkre, Thomas A. Waldmann, Christian M. Capitini, Lixin Rui
Journal: Blood
Blood (2023) 142 (22): 1879–1894.
https://doi.org/10.1182/blood.2023020142
Published: 2023
Includes: Supplemental data
Journal Articles

DNMT3A-Mediated Oxidative Phosphorylation and Ibrutinib Resistance in Mantle Cell Lymphoma

Nguyet Minh Hoang, Yunxia Liu, Lixin Rui
Journal: Blood
Blood (2022) 140 (Supplement 1): 8762–8763.
https://doi.org/10.1182/blood-2022-166752
Published: 2022
Journal Articles

Targeting EGR1-Medited Metabolic Reprogramming to Overcome Ibrutinib Resistance in Aggressive B Cell Lymphomas

Lixin Rui
Journal: Blood
Blood (2022) 140 (Supplement 1): 6443.
https://doi.org/10.1182/blood-2022-162560
Published: 2022
Journal Articles

Fedratinib and Venetoclax Have Synergistic Activity Against B-Cell Acute Lymphoblastic Leukemia in Vitro

Sean P Rinella, Haley C Bell, Lei Shi, Lixin Rui, Christian M. Capitini
Journal: Blood
Blood (2021) 138 (Supplement 1): 1241.
https://doi.org/10.1182/blood-2021-152909
Published: 2021
Journal Articles

Genetically Defined Metabolic Targets Overcome Ibrutinib Resistance in Mantle Cell Lymphoma

Liang Zhang, MD PhD, Hui Guo, PhD, Hui Zhang, Yixin Yao, PhD, Yang Liu, MD, Shaojun Zhang, PhD, Lixin Rui, PhD, Linghua Wang, PhD, Krystle Nomie, PhD, Michael L. Wang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 395.
https://doi.org/10.1182/blood-2019-125934
Published: 2019
Journal Articles

Oncogenic Cooperation between EGR1 and BRD4 in Diffuse Large B Cell Lymphoma

Lixin Rui, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1508.
https://doi.org/10.1182/blood-2019-124839
Published: 2019
Journal Articles

Gene Regulation and Suppression of Type I Interferon Signaling By STAT3 in Diffuse Large B-Cell Lymphoma

Lixin Rui, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4032.
https://doi.org/10.1182/blood.V130.Suppl_1.4032.4032
Published: 2017
Journal Articles

Nuclear Import of Janus Kinase 1 Is Mediated By Multiple Alpha Importins and Is Required for the Survival of Diffuse Large B-Cell Lymphoma

Lixin Rui, PhD
Journal: Blood
Blood (2016) 128 (22): 780.
https://doi.org/10.1182/blood.V128.22.780.780
Published: 2016
Journal Articles

FBXO10 Targets HGAL for Degradation

Fengjie Guo, PhD, Xiaoyu Jiang, PhD, Domenico Roberti, Lixin Rui, PhD, Izidore S Lossos, MD
Journal: Blood
Blood (2015) 126 (23): 3904.
https://doi.org/10.1182/blood.V126.23.3904.3904
Published: 2015
Journal Articles

Synergistic Co-Targeting of BTK and BCL2 in Mantle Cell Lymphoma

Yangguang Li, PhD, Myriam N. Bouchlaka, BS, PhD, Kreg Grindle, Brad S Kahl, MD, Shigeki Miyamoto, David T Yang, MD, Christian M. Capitini, MD, Lixin Rui, PhD
Journal: Blood
Blood (2015) 126 (23): 708.
https://doi.org/10.1182/blood.V126.23.708.708
Published: 2015
Journal Articles

Inventory of STAT3 Splice Variants in ABC- and GCB-DLBCL

Keren B Turton, Deane F. Mosher, MD, Lixin Rui, PhD, Stephane Esnault, PhD, Douglas S Annis
Journal: Blood
Blood (2014) 124 (21): 5180.
https://doi.org/10.1182/blood.V124.21.5180.5180
Published: 2014
Journal Articles

Epigenetic Gene Regulation By JAK1 In Diffuse Large B-Cell Lymphoma

Lixin Rui, PhD
Journal: Blood
Blood (2013) 122 (21): 1263.
https://doi.org/10.1182/blood.V122.21.1263.1263
Published: 2013